10/28/2024
7:23 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:24 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
7:09 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
09/19/2024
4:04 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
09/11/2024
3:09 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/14/2024
3:25 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
|
08/12/2024
7:05 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:11 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
3:12 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
| Form SC 13G | |
07/23/2024
7:16 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:32 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
07/15/2024
7:22 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
7:31 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/14/2024
4:29 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:18 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
05/08/2024
4:11 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2024
6:37 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 424B3 | |
04/10/2024
11:15 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form EFFECT | |
04/08/2024
1:46 PM | EcoR1 Capital, LLC (Filed by)
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form SC 13G/A | |
04/03/2024
6:32 AM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:46 PM | LENZ Therapeutics, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
3:31 PM | Alpha Wave Global, LP (Reporting)
Alpha Wave Ventures GP, Ltd (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/28/2024
3:30 PM | Alpha Wave Ventures GP, Ltd (Filed by)
LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form SC 13G | |
03/25/2024
7:32 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:33 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:34 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:36 PM | Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:38 PM | George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:38 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:39 PM | Drapkin Kimberlee C (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:40 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Scheiner Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:40 PM | Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:42 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:42 PM | LENZ Therapeutics, Inc. (Subject)
LENZ Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G/A | |
03/25/2024
7:44 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:44 PM | Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:48 PM | Kolchinsky Peter (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:10 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:14 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Odrich Marc (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:18 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Olsson Shawn (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
03/25/2024
7:20 PM | Chevallard Daniel R. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:22 PM | George Jeffrey P. (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:24 PM | Guerard Frederic (Reporting)
LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:26 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
MCCOLLUM JAMES W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
7:28 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Thunen Shelley B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
3:19 PM | LENZ Therapeutics, Inc. (Issuer)
LENZ Therapeutics (Issuer)
Versant Venture Capital VII, L.P. (Reporting)
Versant Ventures VII GP, L.P. (Reporting)
Versant Ventures VII GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/19/2024
3:31 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
3:37 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
4:17 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form 425 | |
03/08/2024
4:13 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:08 AM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:09 AM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form 425 | |
02/09/2024
4:23 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-4/A | |
02/05/2024
3:57 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-4/A | |
02/05/2024
3:48 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
02/05/2024
3:31 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
Porteus Matthew (Filed by)
| Form SC 13G/A | |
01/17/2024
8:02 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-4/A | |
12/26/2023
3:37 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form 425 | |
12/26/2023
3:32 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:57 PM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/17/2023
3:38 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/15/2023
4:23 PM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form 425 | |
11/15/2023
7:06 AM | Graphite Bio, Inc. (Filer)
LENZ Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
7:09 AM | Graphite Bio, Inc. (Subject)
LENZ Therapeutics (Subject)
| Form 425 | |
